DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/26x3t5/neisseriaceae_infe) has announced the addition of Global Markets Direct's new report "Neisseriaceae Infections - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Neisseriaceae Infections - Pipeline Review, H1 2012', provides an overview of the Neisseriaceae Infections therapeutic pipeline. This report provides information on the therapeutic development for Neisseriaceae Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neisseriaceae Infections. 'Neisseriaceae Infections - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- A snapshot of the global therapeutic scenario for Neisseriaceae Infections.
- A review of the Neisseriaceae Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Neisseriaceae Infections pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Neisseriaceae Infections.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Neisseriaceae Infections pipeline depth and focus of Neisseriaceae Infections therapeutics.
Keywords
Neisseriaceae Infections Therapeutic Products under Development, Key Players in Neisseriaceae Infections Therapeutics, Neisseriaceae Infections Pipeline Overview, Neisseriaceae Infections Pipeline, Neisseriaceae Infections Pipeline Assessment
For more information visit http://www.researchandmarkets.com/research/26x3t5/neisseriaceae_infe
Source: Global Markets Direct